Loading…
Roundtable Discussions clear filter
arrow_back View All Dates
Wednesday, September 25
 

11:15am PDT

Roundtables
Wednesday September 25, 2024 11:15am - 12:00pm PDT
Optimizing MSL Productivity: Strategies for Success and Retention
  • Discuss practical strategies for showcasing MSL productivity through tangible performance metrics and outcomes
  • Explore insights into fostering a supportive workplace culture to boost MSL retention and career satisfaction
  • Hear ways to utilize technology and innovative tools to streamline MSL activities and enhance overall effectiveness in the field
Lynn Bass, Pharm.D., Senior Director, Medical Science Liaisons, BridgeBio

Measuring Your Omnichannel Impact
  • Define the scope and intricacies of omnichannel strategies in medical affairs.
  • Explore effective methodologies for measuring and evaluating omnichannel success
  • Share challenges faced in implementing and optimizing omnichannel strategies
Stevan Tomich, PharmD, Omnichannel Strategy Lead Oncology, AbbVie 

Integrating Real-World Evidence into Medical Affairs Strategies: Bridging Clinical Development and Field Insights  
  • Address the value of Real-World Evidence (RWE); how this collection of data can help researchers identify the most relevant variables, thereby saving costs and time 
  • Explore how the role of RWE has shifted from a supplementary resource to a more strategic and central component in medical affairs activities and discuss its impact on informing clinical development and decision-making processes.  
  • Examine best practices for MSLs to work effectively with clinical development teams, leveraging RWE to enhance strategic planning, optimize trial designs, and address emerging data needs.  
  • Discuss strategies for efficiently incorporating real-world data into medical affairs practices to meet the increasing requests from stakeholders and improve overall value and patient outcomes.  
Sue Malecha, PharmD, MBA, Senior Director, Medical Affairs, Gilead 
Speakers
avatar for Susan Malecha, PharmD

Susan Malecha, PharmD

Senior Director, Medical Affairs, Gilead
Susan Malecha is a results-driven versatile medical professional with a proven track record for achievement in the pharmaceutical/biotechnology industry. An accomplished author, she has lectured extensively and is called upon to present the latest developments in the areas of Medical... Read More →
Wednesday September 25, 2024 11:15am - 12:00pm PDT
San Diego Marriott Del Mar

3:45pm PDT

Roundtables
Wednesday September 25, 2024 3:45pm - 4:30pm PDT
Optimizing MSL Productivity: Strategies for Success and Retention
  • Discuss practical strategies for showcasing MSL productivity through tangible performance metrics and outcomes
  • Explore insights into fostering a supportive workplace culture to boost MSL retention and career satisfaction
  • Hear ways to utilize technology and innovative tools to streamline MSL activities and enhance overall effectiveness in the field
Jim Wilkinson, Ph.D., US Medical Lead, Medical Affairs & Evidence Generation, Argenx

Measuring Your Omnichannel Impact
  • Define the scope and intricacies of omnichannel strategies in medical affairs.
  • Explore effective methodologies for measuring and evaluating omnichannel success
  • Share challenges faced in implementing and optimizing omnichannel strategies
Stevan Tomich, PharmD, Omnichannel Strategy Lead Oncology, AbbVie

Integrating Real-World Evidence into Medical Affairs Strategies: Bridging Clinical Development and Field Insights  
  • Address the value of Real-World Evidence (RWE); how this collection of data can help researchers identify the most relevant variables, thereby saving costs and time 
  • Explore how the role of RWE has shifted from a supplementary resource to a more strategic and central component in medical affairs activities and discuss its impact on informing clinical development and decision-making processes.  
  • Examine best practices for MSLs to work effectively with clinical development teams, leveraging RWE to enhance strategic planning, optimize trial designs, and address emerging data needs.  
  • Discuss strategies for efficiently incorporating real-world data into medical affairs practices to meet the increasing requests from stakeholders and improve overall value and patient outcomes.  
Sue Malecha, PharmD, MBA, Senior Director, Medical Affairs, Gilead 


Speakers
avatar for Jim Wilkinson, Ph.D.

Jim Wilkinson, Ph.D.

US Medical Lead, Medical Affairs & Evidence Generation, Argenx
Jim Wilkinson, Ph.D. is currently US Medical Lead, Medical Affairs & Evidence Generation with argenx.Jim is an experienced and innovative leader in global and US Medical Affairs, with over 22 years in the biopharma industry. He has worked in several therapeutic areas while also launching... Read More →
avatar for Susan Malecha, PharmD

Susan Malecha, PharmD

Senior Director, Medical Affairs, Gilead
Susan Malecha is a results-driven versatile medical professional with a proven track record for achievement in the pharmaceutical/biotechnology industry. An accomplished author, she has lectured extensively and is called upon to present the latest developments in the areas of Medical... Read More →
Wednesday September 25, 2024 3:45pm - 4:30pm PDT
San Diego Marriott Del Mar
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.
Filtered by Date -